SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Mr. Forthright who wrote (3421)7/18/1998 8:59:00 PM
From: Mike Ankley  Read Replies (2) | Respond to of 5402
 
You continue to mislead. Your statistics are duly noted as being for a first generation drug. You know as well as anyone that PHER-02 is a second generation drug. The first generation drug, Fluosol-DA has already passed the clinical trials and received FDA approval.

Cheers

Mike